Skip to main content

and
  1. Article

    Open Access

    Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules

    The anti-angiogenic fusion protein RBDV-IgG1 Fc (RBDV), which comprises the receptor-binding domain of vascular endothelial growth factor-A (VEGF-A), has shown antitumour effects by reducing angiogenesis in vi...

    Shu-Yi Ho, Pin-Rong Chen, Chia-Hung Chen, Nu-Man Tsai in Journal of Nanobiotechnology (2020)